Schall Law investigates Ducommun over accounting errors
The Schall Law Firm has launched an investigation into Ducommun Incorporated regarding potential securities law violations. The probe stems from Ducommun's May 1, 2026 SEC filing, which revealed an error in stock-based compensation expense recognition, rendering its 2024 and 2025 financial statements unreliable. Subsequently, the company's stock price dropped nearly 3% on May 4, 2026.

*this image is generated using AI for illustrative purposes only.
The Schall Law Firm is investigating Ducommun Incorporated for potential violations of federal securities laws. The investigation focuses on whether the company issued false or misleading statements or failed to disclose material information to investors. This legal scrutiny follows a disclosure by Ducommun regarding significant errors in its historical financial reporting.
Accounting Error Identified
Ducommun disclosed in a Securities and Exchange Commission (SEC) filing dated May 1, 2026, that management identified an error in the company's historical consolidated financial statements. The error specifically relates to the timing of stock-based compensation expense recognition. As a result of this finding, the company stated that previously issued financial statements for 2024 and 2025 should no longer be relied upon.
Market Impact
The announcement of the accounting error had an immediate negative impact on the company's stock price. Based on the news regarding the unreliable financial statements, shares of Ducommun fell by almost 3% on May 4, 2026. This decline reflects investor concerns regarding the accuracy of past financial reports and potential governance issues.
Key Dates and Disclosures
The following timeline outlines the critical events related to the investigation:
| Event | Date |
|---|---|
| SEC Filing Date | May 1, 2026 |
| Share Price Decline | May 4, 2026 |
The Schall Law Firm, a national shareholder rights litigation firm, represents investors globally and specializes in securities class action lawsuits. Investors who suffered losses in Ducommun are encouraged to contact the firm to discuss their rights.
What is the estimated financial magnitude of the stock-based compensation error and how will it impact Ducommun's restated earnings?
Will the SEC expand its investigation beyond the initial filing to include a formal audit of Ducommun's internal accounting controls?
How long will the delay in financial reporting last, and what are the implications for Ducommun's compliance with debt covenants?



















